SCYX

2.3709.02%
GM

Guy MacDonald

Independent Chairman of the Board

Mr. Guy MacDonald, B.Sc., has been an Independent Chairman of SCYNEXIS, Inc. since June 4, 2015. He was the President and Chief Executive Officer of Tetraphase Pharmaceuticals, Inc., since January 2008 until August 1, 2019. Mr. MacDonald lead Tetraphase's drug discovery and development programs, capitalizing on its breakthrough synthetic chemistry platform. He is a veteran of the global pharmaceutical and biotechnology sector. He has a wealth of experience in drug development and commercialization, particularly with anti-infectives including antifungals. He served as an Executive Vice President of Operations of Idenix Pharmaceuticals Inc. from September 2003 to December 31, 2007 and served as its Chief Operating Officer. Mr. MacDonald oversaw the development of Idenix's commercial organization in the U.S. and the top five EU countries and was responsible for regulatory affairs, quality assurance, manufacturing, information technology and project management. He served with Merck & Co., Inc. from November 1981 to August 2003, where he served as a Senior Leader in the areas of virology and anti-infectives and was involved in several landmark launches at a global level and served as Vice President of Anti-Infectives and Hospital Products. He directed the launch of five anti-infective products and led global business strategy for Merck's HIV franchise. He served as the Chairman of Spring Bank Pharmaceuticals, Inc. since March 2010 until September 2015. He has been an Independent Director of SCYNEXIS, Inc. since November 2014. He had been a Director of Tetraphase Pharmaceuticals, Inc. since January 2008 until July 28, 2020 and was a Consultant until December 2019. Mr. MacDonald holds a B.S. in Biochemistry from the University of Dundee, Scotland.

Positions